Home Contact Center Add this

Pipeline

 

NomDescriptionStage
afabicin (Debio 1450), ABSSSI , FabI inhibitor 4 FT / QIDP
Debio 1143, Head & Neck cancer , SMAC mimetic 3.75
Debio 1562 non-Hodgkin lymphoma, anti-CD37 ADC 3.25 ODD
afabicin (Debio 1450), Bone & joint infections , FabI inhibitor 3 ODD / FT / QIDP
Debio 1561 Infectious Diseases, Sample prep. Technology 2.75
Debio 1347 Oncology, FGFR 1,2,3 inhibitor 2.5 ODD
Debio 1143, NSCLC* , SMAC mimetic 2.25
Debio 1124 Oncology, Peptide Radioconjugate 2.0
Debio 025/Musc.Dystrophy , Cyclophilin inhibitor 1.75
Debio 0123 Oncology, Wee1 kinase inhibitor 1
Debio 1453 N.gonorrhoeae, H. pylori, Fabl inhibitor 0.25 CARB-X
Debio 1454 Enteric Species, FabI inhibitor 0.25
Debio 8200** Advanced melanoma resistant, Immunopotentiation 0.25

ODD

Orphan Drug Designation

FT

Fast Track

QIDP

Qualified Infectious Disease Product

CARB-X

Powered by CARB-X



*in combination with avelumab

**in combination with nivolumab

 

Debiopharm Group's projects cover all molecule type proteins, peptides, small molecules